Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseasesRamya Ramaswami, Robert Yarchoan, Priscila Gonçalves et al.|Blood Advances|2021Cited by 78
Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexateKathryn Lurain, Robert Yarchoan, Thomas S. Uldrick et al.|Blood|2020Cited by 45
Chronic lymphocytic leukaemia Australasian consensus practice statementMary Ann Anderson, Stephen P. Mulligan, Rory Bennett et al.|Internal Medicine Journal|2023Cited by 12
Characteristics and outcomes of Kaposi sarcoma herpesvirus–associated inflammatory cytokine syndromeRamya Ramaswami, Robert Yarchoan, Kathryn Lurain et al.|Blood Advances|2025Cited by 12
Treatment Outcomes and Prognostic Factors in 40 Patients with Primary Effusion LymphomaKrithika Shanmugasundaram, Kathryn Lurain, Ramya Ramaswami et al.|Blood|2021Cited by 7